1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2018-2029)
2.2 Over The Counter (OTC) Drugs Growth Trends by Region
2.2.1 Over The Counter (OTC) Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2024-2029)
2.3 Over The Counter (OTC) Drugs Market Dynamics
2.3.1 Over The Counter (OTC) Drugs Industry Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2018-2023)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2022
3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served
3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service
3.7 Date of Enter into Over The Counter (OTC) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2024-2029)
5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2018-2029)
6.2 North America Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
6.3 North America Over The Counter (OTC) Drugs Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2018-2029)
7.2 Europe Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2018-2029)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2018-2029)
9.2 Latin America Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2018-2029)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.1.5 Bayer AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.2.5 Merck KGaA Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Detail
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.6.5 Alkem Laboratories Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.10.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
